Retour sur lavenir.net
   ELIA GROUP 136.700 € (0,00 %)     AB INBEV 70.060 € (+0,57 %)     CENERGY 21.860 € (+0,18 %)     KINEPOLIS GROUP 36.750 € (+0,96 %)     MELEXIS 74.650 € (+3,25 %)     SYENSQO 66.600 € (+0,91 %)     UMICORE 19.880 € (-0,90 %)     D'IETEREN GROUP 173.000 € (+0,06 %)     FAGRON 23.850 € (+0,42 %)     UCB 235.800 € (-0,55 %)     ARGENX SE 766.600 € (+0,37 %)     ASCENCIO 51.400 € (0,00 %)     IBA 17.160 € (+3,13 %)     ATENOR 1.630 € (+0,31 %)     MONTEA 67.300 € (+0,30 %)     CMB.TECH 13.760 € (+2,53 %)     DEME GROUP 165.000 € (-2,14 %)     BIOTALYS 3.000 € (-0,99 %)     ONTEX GROUP 2.210 € (0,00 %)     PROXIMUS 6.070 € (+2,36 %)     SOLVAY 26.100 € (+0,08 %)     AGEAS 70.800 € (+0,07 %)     TUBIZE-FIN 206.800 € (-0,86 %)     WERELDHAVE BELGIUM 53.000 € (+0,38 %)     XIOR 27.550 € (+0,55 %)     ACKERMANS V.HAAREN 265.600 € (-0,90 %)     COLRUYT 37.160 € (+0,76 %)     BARCO 8.340 € (-0,30 %)     BPOST 1.602 € (+0,75 %)     AEDIFICA 69.300 € (+0,14 %)     SOFINA 226.600 € (+0,09 %)     AZELIS GROUP 10.280 € (+0,39 %)     NYRSTAR 0.062 € (+13,09 %)     WDP 21.860 € (+0,18 %)     KBC 119.850 € (-0,29 %)     GBL 77.550 € (-0,26 %)     EVS 27.100 € (-0,55 %)     BREDERODE 102.600 € (-0,77 %)     SIPEF 90.200 € (-0,33 %)     SHURGARD 26.300 € (0,00 %)     AGFA-GEVAERT 0.407 € (-1,21 %)     LOTUS BAKERIES 11 100.000 € (-1,07 %)     VIOHALCO 17.460 € (-1,91 %)     TESSENDERLO 20.450 € (+2,00 %)     EKOPAK 3.795 € (+3,13 %)     RETAIL ESTATES 68.500 € (+0,44 %)     KBC ANCORA 84.000 € (-0,36 %)     IMMOBEL 21.900 € (-0,45 %)     BEKAERT 40.000 € (+0,25 %)     TITAN S.A. 50.450 € (-0,20 %)     RECTICEL 11.400 € (-0,18 %)     HOME INVEST BE. 19.040 € (+0,53 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     GIMV 44.825 € (+0,06 %)     BANIMMO A 2.900 € (0,00 %)     ONWARD MEDICAL 2.585 € (+2,99 %)     TINC 11.280 € (0,00 %)     HYLORIS 4.550 € (-2,15 %)     CARE PROPERTY INV. 12.600 € (0,00 %)     CELYAD ONCOLOGY 0.234 € (+5,41 %)  
   ICADE 18.700 € (+0,32 %)     SCHNEIDER ELECTRIC 267.900 € (-0,65 %)     GTT 188.100 € (0,00 %)     OVH 14.600 € (+0,90 %)     MEXEDIA 3.625 € (-0,14 %)     ELIOR GROUP 2.014 € (+0,20 %)     2CRSI 28.800 € (-6,19 %)     RANDSTAD NV 29.440 € (+2,97 %)     THALES 220.900 € (-1,07 %)     AIR LIQUIDE 174.480 € (+0,10 %)     STEF 123.200 € (+0,16 %)     PERNOD RICARD 63.820 € (-0,59 %)     SAFRAN 331.500 € (-1,37 %)     CAPGEMINI 90.180 € (+1,37 %)     KERING 249.500 € (+0,40 %)     NEXANS 132.200 € (-1,34 %)     UMG 18.995 € (+0,45 %)     KLEPIERRE 36.360 € (+0,61 %)     LVMH 489.600 € (-0,06 %)     SHELL PLC 36.095 € (+1,04 %)     WOLTERS KLUWER 61.080 € (+0,96 %)     WORLDLINE 10.044 € (-1,76 %)     IMERYS 21.300 € (+0,76 %)     RELX 28.600 € (+0,70 %)     AIR FRANCE -KLM 12.985 € (-2,59 %)     SANOFI 76.900 € (+0,88 %)     DBV TECHNOLOGIES 2.860 € (+0,28 %)     STMICROELECTRONICS 61.090 € (-1,47 %)     ASML HOLDING 1 540.200 € (-1,84 %)     MICHELIN 34.690 € (-0,52 %)     GL EVENTS 31.700 € (-0,94 %)     EXOSENS 57.100 € (-1,13 %)     VERALLIA 20.200 € (-0,59 %)     HERMES INTL 1 645.000 € (+0,21 %)     BOUYGUES 46.410 € (-0,62 %)     ORANGE 16.085 € (+1,35 %)     E PANGO 0.126 € (-2,56 %)     LEGRAND 139.350 € (-0,96 %)     BNP PARIBAS ACT.A 100.500 € (-0,20 %)     HAFFNER ENERGY 0.244 € (+1,67 %)     L'OREAL 380.000 € (-0,26 %)     ELIS 25.200 € (-2,02 %)     VEOLIA ENVIRON. 36.330 € (+0,14 %)     SAINT GOBAIN 75.040 € (-1,00 %)     NSI N.V. 17.480 € (-0,11 %)     North Atlantic En. 55.000 € (+4,27 %)     VICAT 60.800 € (-0,98 %)     THX PHARMA 4.005 € (+7,09 %)     UNILEVER 54.070 € (+0,11 %)     BENETEAU 6.050 € (-0,33 %)     DSM FIRMENICH AG 84.180 € (+0,84 %)     CARREFOUR 16.465 € (-0,15 %)     ESSILORLUXOTTICA 169.750 € (-0,96 %)     TOTALENERGIES 69.640 € (+1,84 %)     DASSAULT SYSTEMES 18.380 € (+0,80 %)     ADYEN 851.500 € (+0,58 %)     KALRAY 8.570 € (-0,81 %)     ROCTOOL 1.060 € (-0,93 %)     COFACE 15.730 € (+0,19 %)     DANONE 72.300 € (-0,17 %)  
News Réglementées
24/04/2023 14:00

Fortifeye Vitamins Introduces Super Omega-3 Fish Oil

Dr. Lange of Fortifeye Vitamins discusses the importance of Omega-3 Fish oil

OCALA, FL / ACCESSWIRE / April 24, 2023 / Fortifeye Vitamins introduces Fortifeye Super Omega-3 Fish Oil. Fortifeye Super Omega-3 fish oil is an rTG (Triglyceride) form of omega-3. Understanding the difference in Omega-3 fish oil is crucial for one's health. Many omega-3 supplements that are available over the counter contain ethyl ester molecules, which require the liver to remove the ethanol and replace it with a triglyceride backbone before absorption can occur. This process is not very efficient and may cause instability, unpleasant burping, and potential long-term negative side effects. To avoid these issues, Dr. Lange of Fortifeye Vitamins and the Lange Eye Institute recommends using the more natural rTG form of omega-3 fish oil supplements. Fortifeye Super Omega-3 Max, which was developed by the team of doctors at Fortifeye Vitamins led by Dr. Michael Lange, is one of the purest and most potent Norwegian rTG omega-3 supplements available on the market. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341123/

Dr. Lange in Norway
Dr. Lange in Norway
Dr. Lange visiting Norway doing Omega-3 research

Omega-3 fatty acids, especially EPA and DHA found in fish oil, are known for their anti-inflammatory properties. Inflammation is a natural response of the body to injury or infection, but chronic inflammation can lead to the development of various diseases, such as heart disease, diabetes, and arthritis. Omega-3 fatty acids can help reduce inflammation by suppressing the production of pro-inflammatory molecules and promoting the production of anti-inflammatory molecules. Incorporating omega-3-rich foods or supplements into the diet may offer a natural and safe approach to combat inflammation and its associated health risks.

The positive effects of omega-3 in the human body are numerous, such as providing valuable nutritional support to the heart, eyes, brain, skin, and joints. In addition, omega-3 has been found to support healthy inflammatory response, mood health, sports nutrition, and pre- and post-menopausal health. Unfortunately, the typical American diet is low in omega-3 and high in pro-inflammatory omega-6. It is important to consult with a physician before taking supplements, especially for those who are taking blood thinners. https://www.sciencedaily.com/releases/2020/03/200325131536.htm https://neurosciencenews.com/omega-3-cognition-aging-21580/

A very common complaint from individuals with low omega-3 levels is they experience dry eye symptoms. Studies have demonstrated the positive effects of omega-3 fish oils on dry eye syndrome. It appears that omega-3 fish oils may have a positive impact on both the Meibomian glands and the lacrimal glands. One mechanism by which omega-3 fatty acids may exert their effect is by reducing inflammation in the Meibomian glands, which can result in the healthier secretion of the outer lipid layer of the tear film. When the outer layer of the tear film is healthy, there is less tear evaporation and fewer dry eye symptoms. The omega-3 fatty acids are essential for eye health. https://fortifeye.com/product/fortifeye-super-omega-3-max-dr/
https://www.aao.org/eye-health/tips-prevention/does-fish-oil-help-dry-eye
https://www.healthbenefitsofomega3.com/

Contact Information

Mandy Baker
Director of Marketing
mandy@fortifeye.com
3522391692

SOURCE: Fortifeye Vitamins

.

View source version on accesswire.com:
https://www.accesswire.com/750199/Fortifeye-Vitamins-Introduces-Super-Omega-3-Fish-Oil

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière